Item

An update on the CONCORDE study: A phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC

Horne, A.
; 
Walls, G.
; 
Brown, S.
; 
Chalmers, A.
; 
Franks, K. N.
; 
Harrow, S.
; 
Hassani, A.
; 
Hatton, M.
; 
Hiley, C.
; 
Kendall, J.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Horne, A.
Walls, G.
Brown, S.
Chalmers, A.
Franks, K. N.
Harrow, S.
Hassani, A.
Hatton, M.
Hiley, C.
Kendall, J.
McAleese, J.
Norris, M.
Ojo, O.
Oughton, J. B.
Phillip, R. H.
Rudd, P.
Shaw, P. H.
Walker, F.
Greystoke, A.
Faivre-Finn, C.
Affiliation
Christie NHS Fdn Trust, Manchester, England Clin Trials Unit, Leeds Canc Res UK, Leeds, England Canc Res UK Beatson Inst, Glasgow, Scotland Univ Leeds, Leeds, England Canc Res UK Edinburgh Canc Ctr, Edinburgh, Scotland Freeman Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne, England Sheffield Teaching Hosp NHS Fdn Trust, Weston Pk Hosp, Sheffield, England UCL, Canc Inst, Paul OGorman Bldg, London, England Belfast Hlth & Social Care Trust, Northern Ireland Canc Ctr, Belfast, North Ireland AstraZeneca PLC, Cambridge, England St Bartholomews Hosp, London, England Velindre NHS Univ Trust NHS Wales, Velindre Canc Ctr, Cardiff, Wales Newcastle Univ, Newcastle Upon Tyne, England
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Horne A, Walls G, Brown S, Chalmers A, Franks KN, Harrow S, et al. An update on the CONCORDE study: A phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC. JOURNAL OF THORACIC ONCOLOGY. 2025 MAR;20(3). PubMed PMID: WOS:001502812600049. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627503
Embedded videos